nifedipine has been researched along with Neurodevelopmental Disorders in 2 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Neurodevelopmental Disorders: These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning. (From DSM-5).
Excerpt | Relevance | Reference |
---|---|---|
"The APOSTEL III trial was a multicentre randomised controlled trial that compared tocolysis with nifedipine or atosiban in 503 women with threatened preterm birth." | 5.34 | Effects of tocolysis with nifedipine or atosiban on child outcome: follow-up of the APOSTEL III trial. ( Kleinrouweler, CE; Klumper, J; Mol, BW; Naaktgeboren, CA; Nijman, TA; Oudijk, MA; Pajkrt, E; Roos, C; Roseboom, TJ; Tichelaar, MA; van Baar, AL; van Wassenaer-Leemhuis, AG; van Winden, T; Van't Hooft, J, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
van Winden, T | 1 |
Klumper, J | 1 |
Kleinrouweler, CE | 1 |
Tichelaar, MA | 1 |
Naaktgeboren, CA | 1 |
Nijman, TA | 1 |
van Baar, AL | 1 |
van Wassenaer-Leemhuis, AG | 2 |
Roseboom, TJ | 1 |
Van't Hooft, J | 1 |
Roos, C | 2 |
Mol, BW | 1 |
Pajkrt, E | 1 |
Oudijk, MA | 2 |
van Vliet, E | 1 |
Seinen, L | 1 |
Schuit, E | 1 |
Scheepers, H | 1 |
Bloemenkamp, K | 1 |
Duvekot, JJ | 1 |
van Eyck, J | 1 |
Kok, JH | 1 |
Lotgering, FK | 1 |
van Baar, A | 1 |
Franssen, MT | 1 |
Porath, MM | 1 |
van der Post, J | 1 |
Franx, A | 1 |
Mol, B | 1 |
2 trials available for nifedipine and Neurodevelopmental Disorders
Article | Year |
---|---|
Effects of tocolysis with nifedipine or atosiban on child outcome: follow-up of the APOSTEL III trial.
Topics: Child Behavior Disorders; Child, Preschool; Executive Function; Female; Follow-Up Studies; Health St | 2020 |
Maintenance tocolysis with nifedipine in threatened preterm labour: 2-year follow up of the offspring in the APOSTEL II trial.
Topics: Adult; Analysis of Variance; Double-Blind Method; Female; Fetal Membranes, Premature Rupture; Follow | 2016 |